| EPB122 | Non-invasive identification of severe NAFLD and risk stratification of clinical outcomes using Fibroscan-AST (FAST) score in 1683 people with HIV | E-poster | Hepatic complications (e.g., NASH) |
| EPA002 | Non-canonical role of Hsp90 isoforms in HIV-1 infection | E-poster | HIV biology (entry, replicative cycle, transcriptional expression and regulation) |
| EPB106 | Non-alcoholic to metabolic associated fatty liver disease: cardiovascular implications of a change in terminology in patients living with HIV | E-poster | Other non-communicable diseases |
| EPF101 | No rights, no health: Women Sex Workers in Latin America and the Caribbean build evidence on cases of violence and violation of our rights | E-poster | Legal advocacy tools and strategies |
| EPB229 | No pharmacokinetic interaction between islatravir and methadone | E-poster | Clinical issues in people who use drugs |
| EPF005 | No justice, no peace for people living with HIV: a global analysis of HIV-related criminal cases, 2019-21 | E-poster | Laws and policies on HIV transmission, exposure, and non-disclosure |
| PESAA12 | No evidence that ongoing HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term suppressive ART | Poster exhibition | Systemic immune activation and inflammation |
| EPE157 | No differences in recipients of care perceived quality of care between differentiated service delivery models and conventional care in South Africa | E-poster | Differentiated service delivery for HIV testing, prevention and treatment |
| PEMOB32 | No difference in prevalence of TB infection among infants in two Southern African cohorts by in utero HIV exposure status | Poster exhibition | HIV-exposed uninfected children |
| EPC468 | Nitazoxanide as post exposure prophylaxis (PEP) of COVID-19 household contacts (FH-53 PENTZ) | E-poster | COVID-19 prevention |